G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Market Cap	2.29B -33.4%
Revenue (ttm)	309.13M +24.1%
Net Income	139.20M +36.4%
EPS	2.18 +36.1%
Shares Out	63.72M
PE Ratio	16.47
Forward PE	n/a
Dividend	0.70 (1.95%)
Ex-Dividend Date	Jul 29, 2025

Volume	17,724
Average Volume	48,065
Open	35.90
Previous Close	35.90
Day's Range	35.45 - 36.10
52-Week Range	33.00 - 56.60
Beta	-0.91
RSI	44.67
Earnings Date	May 8, 2026

About G&E Herbal Biotechnology

G&E Herbal Biotechnology Co., Ltd. engages in development and commercialization of novel botanical extraction technology and products in Taiwan. It offers Hepanamin capsules; botanical food supplements; botanical anti-aging cosmetics, such as facial cleansing essence, botanic extract toner, moisturizing cream and serum, and essential oil; smile cream and topical gel; as well as adult products, including lubricants. G&E Herbal Biotechnology Co., Ltd. was founded in 2002 and is based in Tainan City, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 39
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4911

Financial Performance

In 2025, G&E Herbal Biotechnology's revenue was 309.13 million, an increase of 24.13% compared to the previous year's 249.03 million. Earnings were 139.20 million, an increase of 36.38%.